Angelmicin b, a new inhibitor of oncogenic signal transduction, inhibits growth and induces myelomonocytic differentiation of human myeloid leukemia HL-60 cells

MLA

Toshikazu Oki, et al. “Angelmicin b, a New Inhibitor of Oncogenic Signal Transduction, Inhibits Growth and Induces Myelomonocytic Differentiation of Human Myeloid Leukemia HL-60 Cells.” Leukemia Research, vol. 20, June 1996, pp. 491–97. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f7686e55b4253465fbf54bc67b353789&authtype=sso&custid=ns315887.

APA

Toshikazu Oki, Junko Okabe-Kado, Akihiro Yokoyama, Nobuyoshi Tsuruoka, Shigeru Tomoyasu, Yoshio Honma, & Yoshimasa Uehara. (1996). Angelmicin b, a new inhibitor of oncogenic signal transduction, inhibits growth and induces myelomonocytic differentiation of human myeloid leukemia HL-60 cells. Leukemia Research, 20, 491–497.

Chicago

Toshikazu Oki, Junko Okabe-Kado, Akihiro Yokoyama, Nobuyoshi Tsuruoka, Shigeru Tomoyasu, Yoshio Honma, and Yoshimasa Uehara. 1996. “Angelmicin b, a New Inhibitor of Oncogenic Signal Transduction, Inhibits Growth and Induces Myelomonocytic Differentiation of Human Myeloid Leukemia HL-60 Cells.” Leukemia Research 20 (June): 491–97. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f7686e55b4253465fbf54bc67b353789&authtype=sso&custid=ns315887.